The success of treatment of most children with Wilms tumor has made tr
aditional therapeutic research in this group of patients increasingly
difficult. Nevertheless, new insights into the biology of Wilms tumor,
and their possible exploitation for the identification of patients at
high risk of recurrence, have resulted in renewed confidence that the
relatively large proportion of patients with Wilms tumor without thes
e high-risk factors can be cured with minimal therapy.